What is the Y-tunnus number of Avenue Biosciences Oy?

Avenue Biosciences Oy is registered with PRH / YTJ under Y-tunnus 3372987-7.

What is the revenue of Avenue Biosciences Oy?

Avenue Biosciences Oy reported revenue of 40,0 t. € in 2025.

How many employees does Avenue Biosciences Oy have?

Avenue Biosciences Oy employs 8 people as of the latest annual report.

Who is the CEO of Avenue Biosciences Oy?

Katja Marjukka Rosti is the CEO of Avenue Biosciences Oy, in role since 2024.

Who is the chairman of Avenue Biosciences Oy?

Tero-Pekka Alastalo chairs the board of Avenue Biosciences Oy, in role since 2026.

Where is Avenue Biosciences Oy headquartered?

Avenue Biosciences Oy's registered address is Arabiankatu 12.

Riskpilot← Back to search

Get full access

Avenue Biosciences Oy

OYActive

Y-tunnus 3372987-7Arabiankatu 12, 00560 HelsinkiResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2023 · 3 years old8 employees

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2025	2024	2024
Revenue	40	0	0
Staff expenses	−679	−166	−138
EBITDA	−1 428	−290	−191
Depreciation & amort.	−48	−10	−13
EBIT	−1 476	−300	−204
Net financials	−40	49	−12
Profit before tax	−1 516	−251	−216
Tax	−0	−0	−0
Net profit	−1 516	−251	−216

Balance sheet

EUR thousands

Item	2025	2024	2024
Total assets	594	854	1 073
Equity	14	708	959
Long-term debt	408	44	41
Short-term debt	173	101	73
Total debt	581	145	114

Financial ratios

5-year trend

EBITDA margin

<−999 %

This company

15,8 %

Market median

This company

Market median

>999% below market

20242025

Equity ratio

2,3 %

This company

38,2 %

Market median

This company

Market median

94% below market

20242025

Return on equity

<−999 %

This company

18,4 %

Market median

This company

Market median

>999% below market

20242025

Net profit margin

<−999 %

This company

8,1 %

Market median

This company

Market median

>999% below market

20242025

Asset turnover

0,07×

This company

1,12×

Market median

This company

Market median

94% below market

20242025

Debt / equity

41,66×

This company

0,62×

Market median

This company

Market median

>999% above market

20242025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-10-01 – 2024-12-31
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-06-19 – 2024-09-30
View PDF

Avenue Biosciences Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Avenue Biosciences Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Avenue Biosciences Oy